Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01107249 · ClinicalTrials.gov registry record · Phase 2
A Trial of Esophageal and Gastric Stenting for Leak or Perforation
A Phase 2 study of Esophageal or Gastric Perforations and Esophageal or Gastric Leaks, sponsored by The Methodist Hospital Research Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT01107249: Completed Phase 2 study of Esophageal or Gastric Perforations and Esophageal or Gastric Leaks, sponsored by The Methodist Hospital Research Institute.
NCT01107249 is a Phase 2 study of Esophageal or Gastric Perforations and Esophageal or Gastric Leaks that has completed, run by The Methodist Hospital Research Institute. The registered enrollment target is 10 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01107249, a Phase 2 study of Esophageal or Gastric Perforations and Esophageal or Gastric Leaks, has completed, sponsored by The Methodist Hospital Research Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
Long term follow-up of patients treated for esophageal fistulas with a newer occlusive self-expanding covered metal stents compared to traditional stents.
Primary Outcome
By results from all procedures as reported by the surgeon conducting the stenting in relationship to difficulty and/or complications, as well as patient tolerability. When the esophagus can be sealed and any contamination drained, the stents have successfully provided coverage to allow healing of the esophageal wall.
Conditions Studied
Interventions
- DEVICE Boston Scientific Ultraflex or Wallstent stents
Study Locations (1)
Texas
- The Methodist Hospital - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2010-05 |
| Est. Completion | 2014-10 |
| Phase | Phase 2 |
What the finished NCT01107249 record still lists
NCT01107249 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (92% lower).
The record links to 2 conditions, with Esophageal or Gastric Perforations appearing as the primary indexed condition, and to 1 intervention - of which Boston Scientific Ultraflex or Wallstent stents is the first listed.
NCT01107249 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT01107249 about?
NCT01107249 is a clinical study titled "A Trial of Esophageal and Gastric Stenting for Leak or Perforation". Long term follow-up of patients treated for esophageal fistulas with a newer occlusive self-expanding covered metal stents compared to traditional stents.
What is the current status of trial NCT01107249?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 10 participants. The study started on 2010-05. Estimated completion is 2014-10.
What conditions does trial NCT01107249 study?
This clinical trial studies the following conditions: Esophageal or Gastric Perforations, Esophageal or Gastric Leaks.
What interventions are being tested in trial NCT01107249?
The interventions under investigation include: Boston Scientific Ultraflex or Wallstent stents (DEVICE).
Who is sponsoring clinical trial NCT01107249?
This trial is sponsored by The Methodist Hospital Research Institute, which has 126 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01107249 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01107249's enrollment target sits among peer trials
10 1968th of 2000 higher than 12 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia